Genmin Lu - Concepedia

Author

Genmin Lu

Portola Pharmaceuticals (United States)ORCID

Also Known As

G Lu, G. Lu, Genmin Lu, Lu Genmin, Sullenger, Bruce A.

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Portola Pharmaceuticals (United States)McMaster University Population Health Research Institute Children's Hospital of Philadelphia University of Pennsylvania

About

Genmin Lu is an author at Portola Pharmaceuticals (United States) specializing in medicine, thrombosis, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	922
2	Health Sciences	4	4	97
3	Arts	1	1	39
4	Education	1	1	35
5	Language Studies	1	1	39

Genmin Lu

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity Deborah Siegal, John T. Curnutte, Stuart J. Connolly, New England Journal of Medicine	2015	1K
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors Stuart J. Connolly, Mark Crowther, John W. Eikelboom, New England Journal of Medicine	2019	920
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors Stuart J. Connolly, Truman J. Milling, John W. Eikelboom, New England Journal of Medicine	2016	772
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa Genmin Lu, Francis DeGuzman, Stanley J. Hollenbach, Nature Medicine ThrombosisVenous ThrombosisCardiovascular DiseaseIndirect InhibitorsMedicine	2013	689
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Journal of the American Heart Association	2016	196
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors Mark Crowther, M. Manasar.Vandana, Michael Kitt, Blood	2013	115
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal of Edoxaban-Induced Anticoagulation in Healthy Subjects By Andexanet Alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors Mark Crowther, Gallia G. Levy, Genmin Lu, Blood	2014	94
Formation of Factors IXa and Xa by the Extrinsic Pathway Genmin Lu, George Broze, Sriram Krishnaswamy Journal of Biological Chemistry	2004	89
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa Deborah Siegal, Genmin Lu, Janet M. Leeds, Blood Advances	2017	70
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors Manu Thomas Kalathottukaren, A. Louise Creagh, Srinivas Abbina, Blood Advances	2018	64

Page 1